^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

GLI3 expression

i
Other names: GLI3, GLI Family Zinc Finger 3, Glioma-Associated Oncogene Family Zinc Finger 3, Transcriptional Activator GLI3, GLI-Kruppel Family Member GLI3, Zinc Finger Protein GLI3, Oncogene GLI3, GLI3-190, GLI3FL, Greig Cephalopolysyndactyly Syndrome, GLI3 Full-Length Protein, GLI3 Form Of 190 KDa, DNA-Binding Protein, PPDIV
Entrez ID:
Related biomarkers:
11ms
Oncogenic potential of truncated-Gli3 via the Gsk3β/Gli3/AR-V7 axis in castration-resistant prostate cancer. (PubMed, Oncogene)
Intriguingly, solely targeting Gli3 showed effectiveness in inhibiting CRPC cell growth. Overall, our study underscores the clinical significance of Gli3, emphasizing t-Gli3, and provides novel insights into the interplay of the Gsk3β/t-Gli3/AR-V7 axis in CRPC.
Journal
|
AR (Androgen receptor) • GLI1 (GLI Family Zinc Finger 1) • GLI3 (GLI Family Zinc Finger 3) • GSK3B (Glycogen Synthase Kinase 3 Beta)
|
AR splice variant 7 • GLI3 expression
1year
GLI3 Is Required for M2 Macrophage Polarization and M2-Mediated Waldenström Macroglobulinemia Growth and Survival. (PubMed, Int J Mol Sci)
In addition, in vitro polarization of M0 macrophages from M-Gli3-/- was not able to induce M2 markers such as CD163, despite inducing iNos expression (M1 marker). Taken together, these results suggest a role for M2 macrophages in promoting WM cell growth and identify GLI3 as a modulator of macrophage polarization.
Journal
|
CD163 (CD163 Molecule) • GLI3 (GLI Family Zinc Finger 3)
|
GLI3 expression
1year
miR-200c targeting GLI3 inhibits cell proliferation and promotes apoptosis in non-small cell lung cancer cells. (PubMed, Medicine (Baltimore))
miR-200c-3p overexpression in A549 cells could inhibit cell viability and invasion, and promote apoptosis. miR-200c-3p could target GLI3 to regulate cell cycle and inhibit cell proliferation.
Journal
|
MIR200C (MicroRNA 200c) • GLI3 (GLI Family Zinc Finger 3)
|
miR-200-c overexpression • GLI3 expression • GLI3 overexpression • miR-200c-3p overexpression
over1year
A Pilot Immunohistochemical Study Identifies Hedgehog Pathway Expression in Sinonasal Adenocarcinoma. (PubMed, Int J Mol Sci)
This, taken together with a stronger signal of GLI2 in tumors compared to non-tumor tissues, suggests that the Hedgehog pathway is indeed activated in sinonasal adenocarcinoma. As Hedgehog pathway inhibitors are being tested in combination with other therapies for head and neck squamous cell carcinoma, this could provide a therapeutic option for patients with sinonasal adenocarcinoma as well.
Journal
|
PTCH1 (Patched 1) • GLI1 (GLI Family Zinc Finger 1) • GLI3 (GLI Family Zinc Finger 3) • GLI2 (GLI Family Zinc Finger 2)
|
GLI3 expression
almost2years
The comprehensive landscape of prognosis, immunity, and function of the GLI family by pan-cancer and single-cell analysis. (PubMed, Aging (Albany NY))
Additionally, functional enrichment analyses indicated that GLI1/2/3 are involved in the regulation of epithelial-mesenchymal transition (EMT). Together, our findings shed new light on the roles of GLI1/2/3 in tumorigenesis and provide a potential basis for the development of novel therapeutic strategies targeting GLI-mediated signaling pathways in cancer.
Journal • Pan tumor
|
GLI1 (GLI Family Zinc Finger 1) • GLI3 (GLI Family Zinc Finger 3) • GLI2 (GLI Family Zinc Finger 2)
|
GLI1 expression • GLI3 expression
almost2years
Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores. (PubMed, Front Endocrinol (Lausanne))
Our results indicate that GPER is highly expressed in the nucleus and increases with higher grade groups. Additionally, GPER's expression correlates with pGLI3 nuclear expression across different grade groups in PCa tissues; however, whether the receptor induces the activation of GLI transcriptional factors, or the latter modulate the expression of GPER is yet to be discovered, as well as the functional consequence of this correlation.
Journal
|
GLI1 (GLI Family Zinc Finger 1)
|
GLI3 expression
almost2years
Genome-wide association identifies novel ROP risk loci in a multiethnic cohort. (PubMed, Commun Biol)
Relevance for GLI3 and other top-associated genes to human ocular disease was substantiated through in-silico extension analyses, genetic risk score analysis and expression profiling in human donor eye tissues. Thus, we identify a novel locus at GLI3 with relevance to retinal biology, supporting genetic susceptibilities for ROP risk with possible variability by race and ethnicity.
Journal
|
GLI1 (GLI Family Zinc Finger 1) • GLI3 (GLI Family Zinc Finger 3)
|
GLI3 expression
over2years
Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling. (PubMed, Mol Biol Res Commun)
We found that loss of MED12 promotes the expression of GLI3 target genes which subsequently drives excessive cell growth in the absence of androgens. Thus, we conclude that genetic alterations within MED12 promote CRPC through hyperactivated GLI3 dependent sonic hedgehog signaling.
Journal
|
GLI3 (GLI Family Zinc Finger 3)
|
GLI3 expression
over2years
Inhibition of exosome biogenesis reduces cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas (EACR 2023)
These genes were differentially expressed in co-culture versus mono-culture conditions. Moreover, the expression levels of these genes (e.g. PTRZ, GLI3, NTRK2) were significantly modulated upon GW4869 treatment.ConclusionIn conclusion, our study highlights the importance of exosomes in inter-clonal communication and it suggests that interfering with exosome biogenesis may be a valuable strategy to inhibit cell motility in PDHGG.
Clinical
|
NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2) • GLI3 (GLI Family Zinc Finger 3)
|
GLI3 expression
almost3years
Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. (PubMed, 3 Biotech)
We also studied their transcriptional network and functional category enrichment analysis about brain tumor development to find a better therapeutic strategy against brain cancer and their stem cells. The online version contains supplementary material available at 10.1007/s13205-022-03419-5.
Journal
|
GLI1 (GLI Family Zinc Finger 1) • SOX2 • POU5F1 (POU Class 5 Homeobox 1) • SOX9 (SRY-Box Transcription Factor 9) • ENO1 (Enolase 1) • GLI3 (GLI Family Zinc Finger 3) • GLI2 (GLI Family Zinc Finger 2) • NANOG (Nanog Homeobox)
|
GLI3 expression
3years
Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer (clinicaltrials.gov)
P2, N=138, Recruiting, University of Alabama at Birmingham | Trial completion date: Mar 2023 --> Dec 2024 | Trial primary completion date: Jan 2023 --> Nov 2023
Trial completion date • Trial primary completion date
|
TP53 (Tumor protein P53) • CCND1 (Cyclin D1) • PTCH1 (Patched 1) • CDH1 (Cadherin 1) • GLI1 (GLI Family Zinc Finger 1) • HIP1 (Huntingtin Interacting Protein 1) • CASP3 (Caspase 3) • GLI3 (GLI Family Zinc Finger 3) • PCNA (Proliferating cell nuclear antigen) • GLI2 (GLI Family Zinc Finger 2) • SHH (Sonic Hedgehog Signaling Molecule)
|
TP53 expression • GLI3 expression • PCNA expression
over3years
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology. (PubMed, Clin Transl Med)
Overall results highlight the complexity of the disease and a limited chemical space for therapeutic advancement. However, subtle differences between the two EPS subtypes highlight the biological disparities between younger and older EPS patients and emphasise the need to approach the two subtypes as molecularly and clinically distinct diseases.
Journal
|
SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • CXCL12 (C-X-C Motif Chemokine Ligand 12) • GLI3 (GLI Family Zinc Finger 3) • FYN (FYN Proto-Oncogene, Src Family Tyrosine Kinase)
|
CXCL12 expression • GLI3 expression
|
Tazverik (tazemetostat)